Structural–functional analysis of drug target aspartate semialdehyde dehydrogenaseShow others and affiliations
2024 (English)In: Drug Discovery Today, ISSN 1359-6446, E-ISSN 1878-5832, Vol. 29, no 3, article id 103908Article, review/survey (Refereed) Published
Abstract [en]
Aspartate β-semialdehyde dehydrogenase (ASADH) is a key enzyme in the biosynthesis of essential amino acids in microorganisms and some plants. Inhibition of ASADHs can be a potential drug target for developing novel antimicrobial and herbicidal compounds. This review covers up-to-date information about sequence diversity, ligand/inhibitor-bound 3D structures, potential inhibitors, and key pharmacophoric features of ASADH useful in designing novel and target-specific inhibitors of ASADH. Most reported ASADH inhibitors have two highly electronegative functional groups that interact with two key arginyl residues present in the active site of ASADHs. The structural information, active site binding modes, and key interactions between the enzyme and inhibitors serve as the basis for designing new and potent inhibitors against the ASADH family.
Place, publisher, year, edition, pages
Elsevier BV , 2024. Vol. 29, no 3, article id 103908
Keywords [en]
active site, amino acid biosynthesis, ASADH, drug target, microbial inhibitors
National Category
Biochemistry Molecular Biology
Identifiers
URN: urn:nbn:se:kth:diva-343760DOI: 10.1016/j.drudis.2024.103908ISI: 001184676200001PubMedID: 38301800Scopus ID: 2-s2.0-85184755406OAI: oai:DiVA.org:kth-343760DiVA, id: diva2:1839956
Note
QC 20240222
2024-02-222024-02-222025-02-20Bibliographically approved